Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
Verteporfin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/09/2020
Verdinexor
Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020
Velutin
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Velpatasvir
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/26/2021
VBY-825
Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020
Vandetanib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/25/2020
Valrubicin
Potential treatment - theoretical effect Experimental Antiviral Feb/02/2021
Valproic Acid
Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020
Valaciclovir
Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020
Vacuolin-1
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020
Ursonic acid
Potential treatment - theoretical effect Natural product Antiviral Sep/03/2020
Ursolic acid
Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020
URMC-099-C
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
Uridine triphosphate
Potential treatment - theoretical effect Natural product Antiviral Aug/05/2020
Uncaria tomentosa extract
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021
UCN-01
Potential treatment - theoretical effect Experimental Other treatment May/17/2020
U18666A
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020
Tylophorine
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/14/2020
Ty1
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020
Tubocurarine
Potential treatment - theoretical effect Natural product Antiviral Mar/23/2021